Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Apr;21(4):219.
doi: 10.1038/s41579-023-00872-8.

Early treatment for COVID-19

Andrea Du Toit  1
Affiliations
Comment

Early treatment for COVID-19

Andrea Du Toit. Nat Rev Microbiol. 2023 Apr.

Abstract

This study evaluates the efficacy of exogenous pegylated IFNλ in the treatment of patients with COVID-19.

PubMed Disclaimer

Comment on

  • Early Treatment with Pegylated Interferon Lambda for Covid-19.
    Reis G, Moreira Silva EAS, Medeiros Silva DC, Thabane L, Campos VHS, Ferreira TS, Santos CVQ, Nogueira AMR, Almeida APFG, Savassi LCM, Figueiredo-Neto AD, Dias ACF, Freire Júnior AM, Bitarães C, Milagres AC, Callegari ED, Simplicio MIC, Ribeiro LB, Oliveira R, Harari O, Wilson LA, Forrest JI, Ruton H, Sprague S, McKay P, Guo CM, Limbrick-Oldfield EH, Kanters S, Guyatt GH, Rayner CR, Kandel C, Biondi MJ, Kozak R, Hansen B, Zahoor MA, Arora P, Hislop C, Choong I, Feld JJ, Mills EJ, Glenn JS; TOGETHER Investigators. Reis G, et al. N Engl J Med. 2023 Feb 9;388(6):518-528. doi: 10.1056/NEJMoa2209760. N Engl J Med. 2023. PMID: 36780676 Free PMC article. Clinical Trial.

References

    1. Reis G, et al. Early treatment with pegylated interferon lambda for Covid-19. N. Engl. J. Med. 2023 doi: 10.1056/NEJMoa2209760. - DOI - PMC - PubMed